HDAC9 and neoplasm: On the one hand, HDAC inhibitors, by inhibiting histone deacetylase activity, increase the acetylation levels of histones in cells, restoring the expression of some tumor suppressor genes (such as p21 and p27), thereby inhibiting tumor growth [77].